Back to Search
Start Over
699 A differentiated anti-OX40 agonist BGB-A445 does not block OX40-OX40L interaction and reveals remarkable anti-tumor efficacy in preclinical models
- Source :
- Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
- Publication Year :
- 2020
- Publisher :
- BMJ Publishing Group, 2020.
- Subjects :
- Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Subjects
Details
- Language :
- English
- ISSN :
- 20511426
- Volume :
- 8
- Issue :
- Suppl 3
- Database :
- Directory of Open Access Journals
- Journal :
- Journal for ImmunoTherapy of Cancer
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.47bc68f1c87d45afb03b36b018769753
- Document Type :
- article
- Full Text :
- https://doi.org/10.1136/jitc-2020-SITC2020.0699